US Patent 9486512 In situ antigen-generating cancer vaccine
Patent 9486512 was granted and assigned to President and Fellows of Harvard College on November, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9486512 In situ antigen-generating cancer vaccine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
